The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
Congressionally Directed Medical Research Programs (CDMRP) -- Lung Cancer Research Program -- Concept Award
The FY20 LCRP Concept Award supports the exploration of a highly innovative new concept or untested theory that addresses an important problem relevant to lung cancer. The Concept Award is not intended to support an incremental progression of an already established research project but, instead, allows Principal Investigators (PIs) the opportunity to pursue serendipitous observations. This award mechanism supports high-risk studies that have the potential to reveal entirely new avenues for investigation. Applications must describe how the new idea will enhance the existing knowledge of lung cancer or develop an innovative and novel course of investigation. Submissions from and partnerships with investigators at Department of Defense (DoD) military treatment facilities and laboratories, and Department of Veterans Affairs (VA) medical centers and research laboratories are strongly encouraged. Research completed through a Concept Award may generate sufficient preliminary data to enable the PI to prepare an application for future research.
Presentation of preliminary data is not consistent with the intent of the Concept Award mechanism. While the inclusion of preliminary data is not prohibited, the strength of the application should not rely on preliminary data.
- REQUIRED Pre-Application Submission Deadline: May 27, 2020
- Application Submission Deadline: June 10, 2020
Areas of Interest
To be considered for funding, applications for the LCRP Concept Award must address at least one of the nine Areas of Emphasis listed below:
- Identify innovative strategies for prevention of the occurrence of lung cancer.
- Identify innovative strategies for the screening and early detection of lung cancer.
- Understand the molecular mechanisms of initiation and progression to lung cancer.
- Understand contributors to lung cancer development other than tobacco.
- Identify innovative strategies for the treatment of lung cancer.
- Identify innovative strategies for the prevention of recurrence of or metastases from lung cancer.
- Develop or optimize prognostic or predictive markers to assist with therapeutic decisionmaking.
- Understand mechanisms of resistance to treatment (primary and secondary).
- Identify innovative strategies for lung cancer care delivery (disparities/clinical management/ surveillance/symptom management).
Principal Investigator: All investigators at or above the level of postdoctoral fellow (or equivalent) are eligible. An eligible PI, regardless of ethnicity, nationality, or citizenship status, must be employed by, or affiliated with, an eligible organization.
The anticipated direct costs budgeted for the entire period of performance for an FY20 LCRP Concept Award will not exceed $100,000. Refer to Section II.D.5, Funding Restrictions, for detailed funding information.